SEARCH

SEARCH BY CITATION

References

  • Adamou JE, Heinrichs JH, Erwin AL et al. (2001) Identification and characterization of a novel family of pneumococcal proteins that are protective against sepsis. Infect Immun 69: 949958.
  • Aranda J, Garrido ME, Fittipaldi N, Cortes P, Llagostera M, Gottschalk M & Barbe J (2009) Protective capacities of cell surface-associated proteins of Streptococcus suis mutants deficient in divalent cation-uptake regulators. Microbiology 155: 15801587.
  • Campos IB, Darrieux M, Ferreira DM, Miyaji EN, Silva DA, Areas AP, Aires KA, Leite LC, Ho PL & Oliveira ML (2008) Nasal immunization of mice with Lactobacillus casei expressing the Pneumococcal Surface Protein A: induction of antibodies, complement deposition and partial protection against Streptococcus pneumoniae challenge. Microbes Infect 10: 481488.
  • Chen C, Tang J, Dong W et al. (2007) A glimpse of streptococcal toxic shock syndrome from comparative genomics of S. suis 2 Chinese isolates. PLoS One 2: e315.
  • Corbeil LB (2002) Antibodies as effectors. Vet Immunol Immunop 87: 169175.
  • Esgleas M, Li Y, Hancock MA, Harel J, Dubreuil JD & Gottschalk M (2008) Isolation and characterization of alpha-enolase, a novel fibronectin-binding protein from Streptococcus suis. Microbiology 154: 26682679.
  • Etz H, Minh DB, Henics T et al. (2002) Identification of in vivo expressed vaccine candidate antigens from Staphylococcus aureus. P Natl Acad Sci USA 99: 65736578.
  • Feng Y, Zheng F, Pan X et al. (2007) Existence and characterization of allelic variants of Sao, a newly identified surface protein from Streptococcus suis. FEMS Microbiol Lett 275: 8088.
  • Feng Y, Pan X, Sun W et al. (2009) Streptococcus suis enolase functions as a protective antigen displayed on the bacterial cell surface. J Infect Dis 200: 15831592.
  • Ge J, Feng Y, Ji H, Zhang H, Zheng F, Wang C, Yin Z, Pan X & Tang J (2009) Inactivation of dipeptidyl peptidase IV attenuates the virulence of Streptococcus suis serotype 2 that causes streptococcal toxic shock syndrome. Curr Microbiol 59: 248255.
  • Glatman-Freedman A (2006) The role of antibody-mediated immunity in defense against Mycobacterium tuberculosis: advances toward a novel vaccine strategy. Tuberculosis 86: 191197.
  • Granoff DM (2009) Relative importance of complement-mediated bactericidal and opsonic activity for protection against meningococcal disease. Vaccine 27 (suppl 2): B117B125.
  • Haesebrouck F, Pasmans F, Chiers K, Maes D, Ducatelle R & Decostere A (2004) Efficacy of vaccines against bacterial diseases in swine: what can we expect? Vet Microbiol 100: 255268.
  • Hamel J, Charland N, Pineau I, Ouellet C, Rioux S, Martin D & Brodeur BR (2004) Prevention of pneumococcal disease in mice immunized with conserved surface-accessible proteins. Infect Immun 72: 26592670.
  • Higgins R & Gottschalk M (1995) Distribution of Streptococcus suis capsular types in 1994. Can Vet J 36: 320.
  • Kunitomo E, Terao Y, Okamoto S, Rikimaru T, Hamada S & Kawabata S (2008) Molecular and biological characterization of histidine triad protein in group A streptococci. Microbes Infect 10: 414423.
  • Lancefield RC, McCarty M & Everly WN (1975) Multiple mouse-protective antibodies directed against group B streptococci. Special reference to antibodies effective against protein antigens. J Exp Med 142: 165179.
  • Li Y, Gottschalk M, Esgleas M, Lacouture S, Dubreuil JD, Willson P & Harel J (2007) Immunization with recombinant Sao protein confers protection against Streptococcus suis infection. Clin Vaccine Immunol 14: 937943.
  • Liu L, Cheng G, Wang C, Pan X, Cong Y, Pan Q, Wang J, Zheng F, Hu F & Tang J (2009) Identification and experimental verification of protective antigens against Streptococcus suis serotype 2 based on genome sequence analysis. Curr Microbiol 58: 1117.
  • Lun ZR, Wang QP, Chen XG, Li AX & Zhu XQ (2007) Streptococcus suis: an emerging zoonotic pathogen. Lancet Infect Dis 7: 201209.
  • Matthews R & Burnie J (1998) The role of antibodies in protection against candidiasis. Res Immunol 149: 343352; discussion 496–349.
  • Messier S, Lacouture S & Gottschalk M (2008) Distribution of Streptococcus suis capsular types from 2001 to 2007. Can Vet J 49: 461462.
  • Ochs MM, Bartlett W, Briles DE, Hicks B, Jurkuvenas A, Lau P, Ren B & Millar A (2008) Vaccine-induced human antibodies to PspA augment complement C3 deposition on Streptococcus pneumoniae. Microb Pathogenesis 44: 204214.
  • Ogunniyi AD, Grabowicz M, Mahdi LK, Cook J, Gordon DL, Sadlon TA & Paton JC (2009) Pneumococcal histidine triad proteins are regulated by the Zn2+-dependent repressor AdcR and inhibit complement deposition through the recruitment of complement factor H. FASEB J 23: 731738.
  • Reid SD, Montgomery AG, Voyich JM, DeLeo FR, Lei B, Ireland RM, Green NM, Liu M, Lukomski S & Musser JM (2003) Characterization of an extracellular virulence factor made by group A Streptococcus with homology to the Listeria monocytogenes internalin family of proteins. Infect Immun 71: 70437052.
  • Riboldi-Tunnicliffe A, Bent CJ, Isaacs NW & Mitchell TJ (2004) Expression, purification and X-ray characterization of residues 18–230 from the pneumococcal histidine triad protein A (PhtA) from Streptococcus pneumoniae. Acta Crystallogr D 60: 926928.
  • Riboldi-Tunnicliffe A, Isaacs NW & Mitchell TJ (2005) 1.2 Angstroms crystal structure of the S. pneumoniae PhtA histidine triad domain a novel zinc binding fold. FEBS Lett 579: 53535360.
  • Siegel JL, Hurst SF, Liberman ES, Coleman SE & Bleiweis AS (1981) Mutanolysin-induced spheroplasts of Streptococcus mutants are true protoplasts. Infect Immun 31: 808815.
  • Tan C, Fu S, Liu M, Jin M, Liu J, Bei W & Chen H (2008) Cloning, expression and characterization of a cell wall surface protein, 6-phosphogluconate-dehydrogenase, of Streptococcus suis serotype 2. Vet Microbiol 130: 363370.
  • Tang J, Wang C, Feng Y et al. (2006) Streptococcal toxic shock syndrome caused by Streptococcus suis serotype 2. PLoS Med 3: e151.
  • Terao Y, Okamoto S, Kataoka K, Hamada S & Kawabata S (2005) Protective immunity against Streptococcus pyogenes challenge in mice after immunization with fibronectin-binding protein. J Infect Dis 192: 20812091.
  • Timoney JF, Qin A, Muthupalani S & Artiushin S (2007) Vaccine potential of novel surface exposed and secreted proteins of Streptococcus equi. Vaccine 25: 55835590.
  • Waldemarsson J, Areschoug T, Lindahl G & Johnsson E (2006) The streptococcal Blr and Slr proteins define a family of surface proteins with leucine-rich repeats: camouflaging by other surface structures. J Bacteriol 188: 378388.
  • Wang C, Li M, Feng Y et al. (2009) The involvement of sortase A in high virulence of STSS-causing Streptococcus suis serotype 2. Arch Microbiol 191: 2333.
  • Wertheim HF, Nghia HD, Taylor W & Schultsz C (2009) Streptococcus suis: an emerging human pathogen. Clin Infect Dis 48: 617625.
  • Wollert T, Pasche B, Rochon M, Deppenmeier S, van den Heuvel J, Gruber AD, Heinz DW, Lengeling A & Schubert WD (2007) Extending the host range of Listeria monocytogenes by rational protein design. Cell 129: 891902.
  • Zhang A, Chen B, Li R, Mu X, Han L, Zhou H, Chen H & Meilin J (2009) Identification of a surface protective antigen, HP0197 of Streptococcus suis serotype 2. Vaccine 27: 52095213.
  • Zhang Y, Masi AW, Barniak V, Mountzouros K, Hostetter MK & Green BA (2001) Recombinant PhpA protein, a unique histidine motif-containing protein from Streptococcus pneumoniae, protects mice against intranasal pneumococcal challenge. Infect Immun 69: 38273836.